BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis.
Abe, H., Kamimura, K., Okuda, S., Watanabe, Y., Inoue, J., Aoyagi, Y., Wakai, T., Kominami, R., Terai, S. BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis. Cancer Med. 12(14):15650‐15663 (2023).
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi, M., Ling, Y., Toshikawa, C., Hayashida, T., Kitagawa, Y., Futamura, M., Kuwayama, T., Nakamura, S., Yamauchi, H., Yamauchi, T., Kaneko, K., Kanbayashi, C., Sato, N., Tsuchida, J., Moro, K., Nakajima, M., Shimada, Y., Ichikawa, H., Lyle, S., Miyoshi, Y., Takabe, K., Okuda, S., Wakai, T. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients. Breast Cancer 30(4):584-595(2023).
Isolation of the high polyamine-producing bacterium Staphylococcus epidermidis FB146 from fermented foods and identification of polyamine-related genes.
Shirasawa, H., Nishiyama, C., Hirano, R., Koyanagi, T., Okuda, S., Takagi, H., Kurihara, S. Isolation of the high polyamine-producing bacterium Staphylococcus epidermidis FB146 from fermented foods and identification of polyamine-related genes. Biosci. Microbiota Food Health 42(1):24-33(2023).
Glycan-related genes in human gut microbiota exhibit differential distribution and diversity in carbohydrate degradation and glycan synthesis.
Takihara, H., Okuda, S. Glycan-related genes in human gut microbiota exhibit differential distribution and diversity in carbohydrate degradation and glycan synthesis. Front Mol Biosci. 10:1137303(2023).
A biomarker study of atezolizumab (atezo) + bevacizumab (bev) + carboplatin (carbo) + paclitaxel (pac) (ABCP) for patients with NSCLC harboring EGFR mutations (EGFRm) after failure of TKI therapy: NEJ043.
Watanabe, S., Furuya, N., Nakamura, A., Shiihara, J., Nakachi, I., Tanaka, H., Nakao, M., Minato, K., Seike, M., Sasaki, S., Kisohara, A., Takeuchi, S., Honda, R., Takamura, K., Ling, Y., Okuda, S., Kagamu, H., Yoshimura, K., Kikuchi, T., Kobayashi, K. A biomarker study of atezolizumab (atezo) + bevacizumab (bev) + carboplatin (carbo) + paclitaxel (pac) (ABCP) for patients with NSCLC harboring EGFR mutations (EGFRm) after failure of TKI therapy: NEJ043. ASCO annual meeting 2023, Chicago (2023/6/4).
Escherichia coli-derived outer-membrane vesicles induce immune activation and progression of cirrhosis in mice and humans.
Natsui, K., Tsuchiya, A., Imamiya, R., Osada-Oka, M., Ishii, Y., Koseki,Y., Takeda, N., Tomiyoshi, K., Yamazaki, F., Yoshida, Y., Ohashi, R., Ling, Y., Ueda, K., Moritoki, N., Sato, K., Nakajima, T., Hasegawa, Y., Okuda, S., Shibata, S., Terai, S. Escherichia coli-derived outer-membrane vesicles induce immune activation and progression of cirrhosis in mice and humans. Liver Int. 43(5):1126-1140(2023).
Current progress and critical challenges to overcome in the bioinformatics of mass spectrometry-based metaproteomics.
Miura, N., Okuda, S. Current progress and critical challenges to overcome in the bioinformatics of mass spectrometry-based metaproteomics. Comput. Struct. Biotechnol. J. 21:1140-1150 (2023).
The ProteomeXchange consortium at 10 years: 2023 update.
Deutsch, E. W., Bandeira, N., Perez-Riverol, Y., Sharma, V., Carver, J. J., Mendoza, L., Kundu, D. J., Wang, S., Bandla, C., Kamatchinathan, S., Hewapathirana, S., Pullman, B. S., Wertz, J., Sun, Z., Kawano, S., Okuda, S., Watanabe, Y., MacLearn B., MacCoss, M. J., Zhu, Y., Ishihama, Y.,Vizcaíno, J. A. The ProteomeXchange consortium at 10 years: 2023 update. Nucleic Acids Res. 51(D1):D1539-D1548(2022).
Elucidating the multiple genetic alterations involved in the malignant transformation of a KRAS mutant neurenteric cyst. A case report.
Saito, S., Natsumeda, M., Sainouchi, M., Takino, T., Shibuya, K., On, J., Kanemaru, Y., Ogura, R., Okada, M., Oishi, M., Shimada, Y., Wakai, T., Okuda, S., Ajioka,Y., kakita, A., Fujii, Y. Elucidating the multiple genetic alterations involved in the malignant transformation of a KRAS mutant neurenteric cyst. A case report. Neuropathology 42(6):519-525 (2022).
Deep learning classification of urinary sediment crystals with optimal parameter tuning.
Nagai, T., Onodera, O., Okuda, S. Deep learning classification of urinary sediment crystals with optimal parameter tuning. Sci. Rep. 12(1):21178(2022).